http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3250142-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ba2417b2783849bff8c88d1116a6395 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00982 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00994 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-1475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00547 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2034-2051 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1492 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1477 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B10-0233 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-18 |
| filingDate | 2016-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd899f4fed45f8379d17c9cbfef6b186 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_425ec726d09d654e4a34196fae9b51cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0a06b81812d2348d8f71e7dc1437f83 |
| publicationDate | 2017-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3250142-A2 |
| titleOfInvention | Radio-frequency electrical membrane breakdown for the treatment of tissues |
| abstract | An imaging, guidance, planning and treatment system integrated into a single unit or assembly of components, and a method for using same, that can be safely and effectively deployed to treat prostate cancer, unresectable pancreatic cancer, tumors of the breast or soft tissue, including those located in the head, neck, central nervous system or brain, melanoma, ductal carcinoma, neoplasia, or intra and extra luminal abnormal tissue. The system utilizes the novel process of Radio-Frequency Electrical Membrane Breakdown ("EΜΒ" or "RFEMB") to destroy the cellular membranes of unwanted or cancerous tissue without denaturing the intra- cellular contents of the cells comprising the tissue, thereby ablating it and exposing tumor antigens and oilier intra-cellular components which can have an immunologic effect on local or distant cancerous tissue., with or without the addition of immunologic adjuvant, drugs., agents, or materials. The system preferably comprises at least one EMB treatment probe (20), at least one trackable biopsy needle (200), at least one trackable anesthesia needle (300), and at least one controller unit for at least partially automating the treatment process. |
| priorityDate | 2015-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.